We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > anticoagulants

News List

The dark side of anticoagulants: will a new approach shed any light? pharmaceutical-technology
June 17, 2020
Anticoagulants are life-saving medicines, but they also raise the risk of patients haemorrhaging and bleeding to death.
Continuous Anticoagulants + Cold Snare Polypectomy Noninferior drugs
July 18, 2019
Continuous Anticoagulants + Cold Snare Polypectomy Noninferior.
Oral anticoagulants and antiplatelets linked to poor outcome in atrial fibrillation europeanpharmaceuticalreview
August 31, 2018
The results challenged the use of combined oral anticoagulant and antiplatelet therapy in patients with atrial fibrillation, especially those without an indication for antiplatelet therapy.
Anticoagulants study shows lower risk of major bleeds pharmaceutical-technology
July 12, 2018
The University of Nottingham’s Division of Primary Care investigated the risks and benefits of the three most common types of direct anti-coagulants (DOACs), apixaban, dabigatran and rivaroxaban, compared with the current main treatment warfarin for patie